Biotech Top Losers: Geron Corporation (NASDAQ:GERN), Synta Pharmaceuticals (NASDAQ:SNTA), Northwest Biotherapeutics (NASDAQ:NWBO), AEterna Zentaris (NASDAQ:AEZS)

Geron Corporation (NASDAQ:GERN) said the US Food and Drug Administration ordered a halt to trials of a cancer drug over concerns about potential liver damage. Geron Corporation (NASDAQ:GERN) stock performance was -61.59% in last session and finished the day at $1.69. Traded volume was 46,444,384 million shares in the last session and the average volume of the stock remained 4.64 million shares. The beta of … Continue reading Biotech Top Losers: Geron Corporation (NASDAQ:GERN), Synta Pharmaceuticals (NASDAQ:SNTA), Northwest Biotherapeutics (NASDAQ:NWBO), AEterna Zentaris (NASDAQ:AEZS)

Chris Lewis03/1303/13

Biotech Top Gainers: OXiGENE (NASDAQ:OXGN), AEterna Zentaris (NASDAQ:AEZS), Marina Biotech (OTCMKTS:MRNA), Dicerna Pharmaceuticals (NASDAQ:DRNA)

Shares of Oxigene Inc (NASDAQ:OXGN) more than doubled on very heavy volume after the microcap biotech said a mid-stage study of its drug Zybrestat, when used with Roche’s Avastin, showed increased survival in ovarian cancer patients. OXiGENE Inc (NASDAQ:OXGN) stock performance was 17.48% in last session and finished the day at $2.42. Traded volume was 6,334,713 million shares in the last session and the average … Continue reading Biotech Top Gainers: OXiGENE (NASDAQ:OXGN), AEterna Zentaris (NASDAQ:AEZS), Marina Biotech (OTCMKTS:MRNA), Dicerna Pharmaceuticals (NASDAQ:DRNA)

Jason Knox03/1203/12